January 22, 2017
Please join us in congratulating Dr. Pengbo Zhou on receiving a $1.3M 5-year R01 from the National Cancer Institute (NCI).
Pengbo Zhou, PhD Professor of Pathology and Laboratory Medicine
The focus of the study is to establish the mechanistic role of the CUL4B ubiquitin ligase in the pathogenesis of colon cancer. Dr. Zhou will also identify small molecule inhibitors of CUL4B and test their efficacy in treating colon cancer.
Congratulations, Dr. Zhou!